GLAXOSMITHKLINE PHARMACEUTICALS LTD. - Announcement under Regulation 30 (LODR)-Change in Directorate

Pursuant to Regulation 30 and Schedule Ill (A) (7) of the Listing and Disclosure Requirements Regulations, 2015, we wish to inform you that the Board of Directors at its meeting held on 7th January 2021 have approved the following changes in Board of Directors of the Company.<BR>